ARCA BIOPHARMA, INC. Trademark Portfolio
ARCA BIOPHARMA, INC. owns 0 live USPTO trademarks across 4 Nice classes. Earliest filing: 2001-12-31; most recent: 2023-12-22.
Portfolio Overview
| Total Marks | 47 |
|---|---|
| Live Marks | 0 |
| Registered | 0 |
| Pending | 0 |
| Earliest Filing | 2001-12-31 |
| Latest Filing | 2023-12-22 |
Top Classes
Class 005 (Pharmaceuticals), Class 044 (Medical Services), Class 035 (Advertising & Business), Class 042 (Software & IT)
Recently Filed Applications
- ARCA — filed 2023-12-22 (Abandoned)
- ARCA BIOPHARMA — filed 2021-11-10 (Abandoned)
- ARCA BIOPHARMA — filed 2020-09-29 (Abandoned)
- ARCA — filed 2020-06-23 (Abandoned)
- GENCARO BUCINDOLOL HCL — filed 2020-06-11 (Abandoned)
Top Marks
- ARCA DISCOVERY — Cancelled
- ARCA — Abandoned
- ARCA BIOPHARMA — Abandoned
- ARCA BIOPHARMA — Abandoned
- ARCA — Abandoned
- GENCARO BUCINDOLOL HCL — Abandoned
- GENCARO — Abandoned
- ARCA BIOPHARMA — Abandoned
- THE GENCARO TEST — Abandoned
- GENCARO BUCINDOLOL HCL — Abandoned
- ARCA BIOPHARMA — Abandoned
- ARCA — Abandoned
- GENCARO — Abandoned
- GENCARO BUCINDOLOL HCL — Abandoned
- ARCA BIOPHARMA — Abandoned
- ARCA — Abandoned
- ARCA BIOPHARMA — Abandoned
- GENCARO — Abandoned
- GENCARO BUCINDOLOL HCL — Abandoned
- Trademark 77730834 — Abandoned
- ARCA BIOPHARMA — Abandoned
- Trademark 77722988 — Abandoned
- GEN4HF — Abandoned
- GEN4HF THE INTEGRATED GENETICS REGISTRY FOR HEART FAILURE — Abandoned
- PIONEERING PERSONALIZED CARDIOVASCULAR THERAPIES — Abandoned
- CARDIOGENE TEST — Abandoned
- GENRECEP TEST — Abandoned
- GENCARO TEST — Abandoned
- THE GENCARO TEST — Abandoned
- TYGERA — Abandoned
- TYGERIN — Abandoned
- ARCA — Abandoned
- ARCA BIO — Abandoned
- ARCA BIOPHARMA — Abandoned
- ARCA BIOPHARMACEUTICALS — Abandoned
- TIGEREL — Abandoned
- TIGERIN — Abandoned
- TIGRIL — Abandoned
- SOLACOR — Abandoned
- SOLIPAX — Abandoned
- SOLIGEN — Abandoned
- TARGIPAX — Abandoned
- TARGIVEN — Abandoned
- VANCORDA — Abandoned
- GENCIVA — Abandoned
- GENCARO — Abandoned
- TARGEX — Abandoned